Similar articles

• Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.

  DeLuca HF, Avioli LV. DeLuca HF, et al. Arch Intern Med. 1970 Nov;126(5):896-9. Arch Intern Med. 1970. PMID: 4319937 No abstract available.
• Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.

  Hirooka M, Wako H, Kaneko C, Ishikawa M, Sasaki S. Hirooka M, et al. J Nutr Sci Vitaminol (Tokyo). 1975;21(4):277-85. doi: 10.3177/jnsv.21.277. J Nutr Sci Vitaminol (Tokyo). 1975. PMID: 1214180
• I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

  Catto GR, MacLeod M, Pelc B, Kodicek E. Catto GR, et al. Br Med J. 1975 Jan 4;1(5948):12-4. doi: 10.1136/bmj.1.5948.12-a. Br Med J. 1975. PMID: 1120218 Free PMC article.
• Disorders of calcium and bone metabolism in chronic renal failure.

  Avioli LV. Avioli LV. Mod Treat. 1970 May;7(3):675-85. Mod Treat. 1970. PMID: 4920810 Review. No abstract available.
• Recent clinical correlates of vitamin D metabolites and calcium metabolism.

  [No authors listed] [No authors listed] Nutr Rev. 1975 Jul;33(7):209-10. doi: 10.1111/j.1753-4887.1975.tb05217.x. Nutr Rev. 1975. PMID: 1097964 Review. No abstract available.